[Pemphigus and herpes: Multicentre survey and literature review].
M Merlant,
V Seta,
P Bernard,
Slim FOURATI,
JF Meritet,
P Wolkenstein,
N Dupin,
P Joly,
O Chosidow,
S Ingen-Housz-Oro,
Ann Dermatol Venereol. 01/08/2018;145(8-9) : 477-485 10.1016/j.annder.2018.03.169. 14/06/2018
Characterization of the anti-hepatitis C virus activity of new non-peptidic small-molecule cyclophilin inhibitors with a potential for broad anti-Flaviviridae activity.
Quentin NEVERS,
Isaac RUIZ,
Nazim AHNOU,
F Donati,
Rozenn BRILLET,
Laurent SOFTIC,
M Chazal,
N Jouvenet,
Slim FOURATI,
Camille BAUDESSON,
Patrice BRUSCELLA,
M Gelin,
JF Guichou,
Jean-Michel PAWLOTSKY,
Abdelhakim AHMED-BELKACEM,
Antimicrob Agents Chemother. 14/05/2018;AAC : 00126-18 10.1128/AAC.00126-18
Viral kinetics analysis and virological characterization of treatment failures in patients with chronic hepatitis C treated with sofosbuvir and an NS5A inhibitor
Slim FOURATI,
J Guedj,
Stephane CHEVALIEZ,
THT Nguyen,
F Roudot-Thoraval,
Isaac RUIZ,
Alexandre SOULIER,
G Scoazec,
A Varaut,
Lila POITEAU,
Murielle FRANCOIS,
A Mallat,
Christophe HEZODE,
Jean-Michel PAWLOTSKY,
Aliment Pharmacol Ther. 01/03/2018;47(5) : 665-673 10.1111/apt.14478. 22/12/2017
Sofosbuvir-Daclatasvir-Simeprevir Plus Ribavirin in Direct-Acting Antiviral-Experienced Patients With Hepatitis C.
Christophe HEZODE,
Slim FOURATI,
Stephane CHEVALIEZ,
G Scoazec,
Alexandre SOULIER,
A Varaut,
M Francois,
Isaac RUIZ,
F Roudot-Thoraval,
A Mallat,
Jean-Michel PAWLOTSKY,
Clin Infect Dis. 01/06/2017;64(11) : 1615-1618 10.1093/cid/cix214. 24/07/2017